Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| KYNAM CAPITAL MANAGEMENT LP | 05-15-2024 | 03-31-2024 | 23 | 955,475,956 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| NATERA INC | COM | 1 | $182,920,000 | 2,000,000 | 0.02 | 0.02 | -900,000 | -31.03 | 03-31-2024 |
| SYNDAX PHARMACEUTICALS INC | COM | 2 | $134,708,000 | 5,660,000 | 0.01 | 0.01 | 2,397,996 | 73.51 | 03-31-2024 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 3 | $121,713,000 | 2,900,000 | 0.01 | 0.01 | 300,000 | 11.54 | 03-31-2024 |
| ARGENX SE | SPONSORED ADR | Liquidated | $0 | 0 | 0.01 | 0.00 | 179,800 | 3995.56 | 03-31-2024 |
